Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pelican Technology Holdings
- Ownership
- Private
- Development stage
- Other
01
Overview
Pelican Technology Holdings operated a commercial protein expression and manufacturing platform (Pelican Expression Technology) used in at least five approved medicines and in licensed products such as the conjugate-vaccine carrier protein PeliCRM197 and Prima RNApols for mRNA manufacturing, generating royalty revenues through partners rather than running its own therapeutic clinical trials.[1][2][6][9][12]
- Therapeutic areas
- Infectious Diseases
- Modalities
- ProteinRecombinant proteinVaccinemRNA-based drugsBiologic
- Industry
- Non-Drug Biotech
02
Partnerships
Ligand PharmaceuticalsMerckJazz PharmaceuticalsAlvogenSerum Institute of IndiaArcellxArcturus Therapeutics
Beyond the preview
Go deeper on Pelican Technology Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pelican Technology Holdings.